The latest market report published by Credence Research, Inc. “Blood Dialyzer Market: Growth, Future Prospects, and Competitive Analysis, 2019 – 2027” the blood dialyzer market was valued at US$ 4,126.2 Mn in 2018, expected to grow at a CAGR of 7.0% during the forecast period from 2019 to 2027.
The global blood dialyzer market is increasing efficiently from 2019 to 2027 accredited to increase in hospital admissions for kidney failure patients along with end stage renal diseases globally. Increasing U.S FDA approvals for new high flux membrane products with upgraded technology will drive the market growth in the near future. Increasing merger & acquisitions, partnerships and product launch will drive the market growth in the near future. For e.g. in July 2018 Becton, Dickinson and Company acquired TVA Medical, develops solutions for patients with kidney disease requiring haemodialysis. Additionally, in November 2017, Nipro Medical Corporation launched a single-use dialyzer, Cellentia-H cellulose triacetate, at the 2017 American Society of Nephrology Kidney Week Conference.
Topmost companies are mainly focusing on new product development and FDA clearance on a global scale, mainly in the U.S. and Europe. Increasing number of partnerships with hospitals and dialysis centers internationally will boost the market growth. Additionally, preference for conventional home hemodialysis, short daily home hemodialysis, and nocturnal home hemodialysis will drive the demand globally. The prominent position of the U.S. market attributed to increasing prevalence of renal disorders, diabetes, endstage renal disease (ESRD), hypertension, and large pool of geriatric population, better reimbursement structure and domicile of major players in North America region. The key factors responsible for driving the market are market growth of in-center dialysis and technology expansion in home care, rising preference for single use dialyzers, increasing awareness associated with advanced techniques and renal therapy procedures, and product expansion in the developing nations along with new and easy-to-use machines will further spur revenue growth globally.
Key Market Movements:
- Globally, the blood dialyzer is growing at a CAGR of 7.0% for the period from 2019 to 2027
- Increasing public health awareness and inexpensive reimbursement scenario drive the market growth the Asia Pacific Europe and region owing to improvements in healthcare infrastructure, rise in healthcare expenditure, and medical tourism
- Increasing funding by private organizations for expansion of dialysis centers for better treatment options
- Increasing partnerships, new product launch and acquisitions will drive the market growth
- Major players in this vertical are Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., B. Braun Melsungen AG, Diaverum Deutschland GmbH, NIPRO Medical Corporation, Medica Group, Dialifegroup, Asahi Kasei, NIKKISO CO., LTD., Allmed Medical Care Holdings Limited, Farmasol, Serumwerk Bernburg AG and others
Browse Full report At https://www.credenceresearch.com/report/blood-dialyzer-market
The Global Blood Dialyzer Market is Segmented into:
|Segmentation||By Product Type (2017–2027; US$ Mn)|
|By Membrane Type (2017–2027; US$ Mn)|
|By End User Segment (2017–2027; US$ Mn)|
|By Geography Segment (2017–2027; US$ Mn)|
*Complete segmentation list is on report page